Published in BMJ on October 09, 2004
Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2012) 0.87
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci (2008) 0.87
Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review. Eur Arch Psychiatry Clin Neurosci (2006) 0.81
The influence of phytotherapy on macroprolactinoma size. Afr J Tradit Complement Altern Med (2011) 0.81
Depression in adults: drug and physical treatments. BMJ Clin Evid (2007) 0.78
Selective serotonin reuptake inhibitors: THREAD trial may show way forward. BMJ (2005) 0.77
Selective serotonin reuptake inhibitors: evidence base for older antidepressants is shaky too. BMJ (2005) 0.75
DNA Damage in Major Psychiatric Diseases. Neurotox Res (2016) 0.75
Selective serotonin reuptake inhibitors: placebo washouts inflate antidepressant effects in general practice. BMJ (2005) 0.75
Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells. Neurotox Res (2015) 0.75
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet (2004) 18.69
Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90
Placebo response in studies of major depression: variable, substantial, and growing. JAMA (2002) 7.56
Antidepressants and the risk of suicidal behaviors. JAMA (2004) 7.08
Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. BMJ (2003) 6.86
Antidepressants and suicide: what is the balance of benefit and harm. BMJ (2004) 3.80
Industry-sponsored clinical research: a double-edged sword. Lancet (2001) 2.45
SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev (2000) 1.48
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry (2002) 1.29
In the dark: drug companies should be forced to publish all the results of clinical trials. New Sci (2004) 1.19
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (2009) 14.52
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet (2011) 6.11
Lithium toxicity profile: a systematic review and meta-analysis. Lancet (2012) 4.82
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry (2004) 4.72
Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry (2006) 4.30
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72
Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol (2006) 3.30
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ (2013) 3.08
Suicide, depression, and antidepressants. BMJ (2005) 2.88
Schizophrenia and violence: systematic review and meta-analysis. PLoS Med (2009) 2.74
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry (2005) 2.64
Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry (2011) 2.47
Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis. Br J Psychiatry (2006) 2.28
Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ (2009) 2.25
Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry (2008) 1.96
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry (2011) 1.89
Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care (2010) 1.82
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry (2013) 1.80
EMA must improve the quality of its clinical trial reports. BMJ (2011) 1.78
Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull (2008) 1.70
Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry (2011) 1.63
The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord (2010) 1.61
Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev (2015) 1.58
Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev (2014) 1.56
Meta-analysis of brain weight in schizophrenia. Schizophr Res (2003) 1.54
Mental imagery as an emotional amplifier: application to bipolar disorder. Behav Res Ther (2008) 1.53
Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol (2005) 1.30
Venlafaxine for major depression. BMJ (2007) 1.20
Long-term treatment of depression with antidepressants: a systematic narrative review. Can J Psychiatry (2007) 1.20
"Wish bias" in antidepressant drug trials? J Clin Psychopharmacol (2004) 1.17
Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can J Psychiatry (2007) 1.14
Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar Disord (2012) 1.09
Personality disorders, violence, and antisocial behavior: a systematic review and meta-regression analysis. J Pers Disord (2012) 1.09
Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis. Int Rev Psychiatry (2009) 1.08
Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery. Behav Res Ther (2011) 1.07
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. J Clin Psychiatry (2008) 1.04
Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol (2004) 1.02
Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes. J Clin Psychiatry (2014) 1.01
Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry (2008) 0.99
Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials. J Psychiatr Pract (2008) 0.99
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis. Stat Med (2012) 0.98
Are all antidepressants really the same? The case of fluoxetine: a systematic review. J Clin Psychiatry (2006) 0.98
Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev (2011) 0.98
Forecasting depression in bipolar disorder. IEEE Trans Biomed Eng (2012) 0.97
Seven criteria for improving effectiveness trials in psychiatry. Psychol Med (2006) 0.94
How psychological symptoms relate to different motivations for gambling: an online study of internet gamblers. Biol Psychiatry (2010) 0.93
Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf (2014) 0.93
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders. Eur J Clin Pharmacol (2012) 0.92
Internet gamblers: a latent class analysis of their behaviours and health experiences. J Gambl Stud (2010) 0.91
Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. Int Clin Psychopharmacol (2006) 0.90
Publication bias in systematic reviews. Arch Gen Psychiatry (2007) 0.89
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev (2015) 0.89
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. Stat Med (2014) 0.88
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol (2007) 0.88
Fluvoxamine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2010) 0.88
Study protocol: The Whitehall II imaging sub-study. BMC Psychiatry (2014) 0.87
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios. Stat Med (2014) 0.87
Depressive disorders. Clin Evid (2004) 0.87
Milnacipran versus other antidepressive agents for depression. Cochrane Database Syst Rev (2009) 0.86
Paroxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2014) 0.86
[¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophr Res (2012) 0.86
Large simple trials in psychiatry: providing reliable answers to important clinical questions. Epidemiol Psichiatr Soc (2005) 0.85
Suicide in prisoners with bipolar disorder and other psychiatric disorders: a systematic review. Bipolar Disord (2013) 0.85
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy. Soc Psychiatry Psychiatr Epidemiol (2005) 0.84
Antidepressant drug prescription and risk of abnormal bleeding: a case-control study. J Clin Psychopharmacol (2009) 0.84
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. J Clin Psychopharmacol (2011) 0.84
Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis. Clin Trials (2013) 0.84
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. Evid Based Ment Health (2008) 0.83
Correlates of depression in bipolar disorder. Proc Biol Sci (2013) 0.83
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. J Clin Psychiatry (2008) 0.83
A cluster randomized controlled trial to assess the effectiveness of an intervention to educate students about depression. Psychol Med (2007) 0.83
Perinatal risk factors in offenders with severe personality disorder: a population-based investigation. J Pers Disord (2012) 0.83
Validity of the impact factor of journals as a measure of randomized controlled trial quality. J Clin Psychiatry (2006) 0.82
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis. CNS Drugs (2008) 0.82
International dosage differences in fluoxetine clinical trials. Can J Psychiatry (2005) 0.82
Mood dynamics in bipolar disorder. Int J Bipolar Disord (2014) 0.81
Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis. J Psychopharmacol (2009) 0.81
Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism. BMC Med (2014) 0.81
Randomized trials published in Chinese or Western journals: comparative empirical analysis. J Clin Psychopharmacol (2012) 0.81
Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2013) 0.80
What is a run-in phase? Epidemiol Psichiatr Soc (2010) 0.80
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia. Eur Neuropsychopharmacol (2013) 0.80
Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol (2003) 0.80
What is the heartland of psychiatry? Br J Psychiatry (2007) 0.79
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review. Mini Rev Med Chem (2008) 0.79
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. Riv Psichiatr (2012) 0.79
Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev (2010) 0.79
Risk of suicidal behaviour in adults taking antidepressants. BMJ (2009) 0.79
Developing the BALANCE trail--the role of the pilot study and start-up phase. Bipolar Disord (2004) 0.79
Azapirones versus placebo for panic disorder in adults. Cochrane Database Syst Rev (2014) 0.78